WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

Wegovy, on the other hand, is eligible for coverage under Medicare only if the eligible overweight or obese patients have pre-existing heart conditions.This group constitutes around 3.6 million ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound from Eli Lilly—has added fuel to an already fiery debate over the ...

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey. FILE - The injectable drug Ozempic is shown, July 1, 2023, in Houston. (AP ...